Latest & greatest articles for ergocalciferol

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on ergocalciferol or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on ergocalciferol and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for ergocalciferol

1. Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients

Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01395823 Recruitment Status : Completed First Posted : July 18, 2011 Results First

2011 Clinical Trials

2. Is there any evidence comparing the efficacy of ergocalciferol or cholecalciferol versus alfacacidol in correcting raised PTH in patients with stage 3 CKD?

Is there any evidence comparing the efficacy of ergocalciferol or cholecalciferol versus alfacacidol in correcting raised PTH in patients with stage 3 CKD? Is there any evidence comparing the efficacy of ergocalciferol or cholecalciferol versus alfacacidol in correcting raised PTH in patients with stage 3 CKD? - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document (...) ’ and this is something we aim to deliver for every single search. As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com Is there any evidence comparing the efficacy of ergocalciferol or cholecalciferol versus

2006 TRIP Answers

3. Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients. Full Text available with Trip Pro

Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients. Vitamin D (25-hydroxyvitamin D; 25[OH]D) deficiency (VDD) is highly prevalent in chronic kidney disease. The aim of this study was to evaluate the effect of oral ergocalciferol supplementation on requirement of erythropoietin (EPO) and active vitamin D analogues, and hospitalization rate in maintenance hemodialysis (HD) patients.This retrospective cohort study included 186 (...) patients who were on HD for 3 months and had 25(OH)D levels < 30 ng/ml. Over 1-year period, 107 patients were supplemented with protocol-based ergocalciferol (D2 group) and 79 were not (control). Parameters of erythropoiesis and bone-mineral metabolism, and monthly doses of EPO and paricalcitol were assessed at 6- and 12- months of ergocalciferol supplementation. Total hospitalizations were recorded for the same year.Baseline characteristics were similar across two arms except higher serum ferritin

2016 BMC Nephrology

4. Vitamin D balance and distribution in rats given a massive dose of ergocalciferol: Part I. Experimental results Full Text available with Trip Pro

Vitamin D balance and distribution in rats given a massive dose of ergocalciferol: Part I. Experimental results 13058881 2003 05 01 2018 12 01 0264-6021 54 2 1953 May The Biochemical journal Biochem. J. Vitamin D balance and distribution in rats given a massive dose of ergocalciferol I. Experimental results. 337-43 CRUICKSHANK E M EM KODICEK E E eng Journal Article England Biochem J 2984726R 0264-6021 0 Ergocalciferols 0 Vitamins 1406-16-2 Vitamin D OM Animals Ergocalciferols Lipid Metabolism

1953 Biochemical Journal

5. Vitamin D balance and distribution in rats given a massive dose of ergocalciferol: Part II. Statistical analysis Full Text available with Trip Pro

Vitamin D balance and distribution in rats given a massive dose of ergocalciferol: Part II. Statistical analysis 13058882 2003 05 01 2018 12 01 0264-6021 54 2 1953 May The Biochemical journal Biochem. J. Vitamin D balance and distribution in rats given a massive dose of ergocalciferol. II. Statistical analysis. 344-7 ARMITAGE P P eng Journal Article England Biochem J 2984726R 0264-6021 0 Ergocalciferols 0 Vitamins 1406-16-2 Vitamin D OM Animals Ergocalciferols Lipid Metabolism Rats Vitamin D

1953 Biochemical Journal

6. The vitamin D content of tissues of rats given ergocalciferol Full Text available with Trip Pro

The vitamin D content of tissues of rats given ergocalciferol 13198870 2003 05 01 2018 12 01 0264-6021 58 1 1954 Sep The Biochemical journal Biochem. J. The vitamin D content of tissues of rats given ergocalciferol. 172-5 CRUICKSHANK E M EM KODICEK E E ARMITAGE P P eng Journal Article England Biochem J 2984726R 0264-6021 0 Ergocalciferols 0 Vitamins 1406-16-2 Vitamin D OM Animals Ergocalciferols Rats Vitamin D analysis Vitamins 5527:10515:497 VITAMIN D/determination 1954 9 1 1954 9 1 0 1 1954 9

1954 Biochemical Journal

7. The effect of ergosterol and ergocalciferol on the anaerobic glycolysis of rat-liver slices Full Text available with Trip Pro

The effect of ergosterol and ergocalciferol on the anaerobic glycolysis of rat-liver slices 14363154 2003 05 01 2018 12 01 0264-6021 59 4 1955 Apr The Biochemical journal Biochem. J. The effect of ergosterol and ergocalciferol on the anaerobic glycolysis of rat-liver slices. 605-9 FESTENSTEIN G N GN eng Journal Article England Biochem J 2984726R 0264-6021 0 Carbohydrates 0 Ergocalciferols 0 Vitamins 1406-16-2 Vitamin D Z30RAY509F Ergosterol OM Animals Carbohydrate Metabolism Carbohydrates (...) Ergocalciferols Ergosterol Glycolysis Liver metabolism Rats Vitamin D pharmacology Vitamins 5528:13988:115:332:609 CARBOHYDRATES/metabolism LIVER/metabolism VITAMIN D/effects 1955 4 1 1955 4 1 0 1 1955 4 1 0 0 ppublish 14363154 PMC1215625 Arch Biochem Biophys. 1953 May;44(1):150-8 13058363 Vitam Horm. 1953;11:29-60 13147056 J Biol Chem. 1951 Feb;188(2):471-6 14824134 Presse Med. 1951 Nov 7;59(70):1454-5 14891712 Biochem Z. 1952 Jan;322(4):245-62 14934713 Biochem J. 1952 Apr;51(1):1-9 14944524 Endocrinology

1955 Biochemical Journal

8. A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women. (Abstract)

A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women. Vitamin D inadequacy is common in institutionalized post-menopausal women who are at the highest risk for osteoporotic fracture.To evaluate efficacy and safety of ergocalciferol 40,000 versus 100,000 IU per week for 12 weeks for vitamin D inadequacy in institutionalized postmenopausal women.A randomized double-blinded (...) placebo-controlled trial was conducted in 94 institutionalized subjects with baseline 25(OH)D levels < 30 ng/mL. Subjects were randomized to receive ergocalciferol 40,000 (standard dose) or ergocalciferol 100,000 IU (high dose) per week. Serum 25(OH)D levels, calcium, phosphate, handgrip strength, time up and go (TUG) test and quality of life by EQ-5D-5L were measured at baseline and 12 weeks after randomization.Of the 94 subjects enrolled, 85 subjects completed the study. Subjects in the high dose

2019 Aging clinical and experimental research Controlled trial quality: predicted high

9. Notice of Retraction: Sato Y, et al. The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer Disease: A Randomized Controlled Trial. Arch Intern Med. 2005;165(15):1737-1742. (Abstract)

Notice of Retraction: Sato Y, et al. The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer Disease: A Randomized Controlled Trial. Arch Intern Med. 2005;165(15):1737-1742. 27258431 2017 10 13 2168-6114 176 9 2016 09 01 JAMA internal medicine JAMA Intern Med Notice of Retraction: Sato Y, et al. The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer

2016 JAMA Internal Medicine Controlled trial quality: uncertain

10. Treatment Effect of Ergocalciferol on Bone Metabolism Indexes and Parathyroid Hormone in Hemodialysis Patients. (Abstract)

Treatment Effect of Ergocalciferol on Bone Metabolism Indexes and Parathyroid Hormone in Hemodialysis Patients. Vitamin D deficiency is a common problem in end-stage renal disease patients under hemodialysis. Both active and nutritional vitamin D supplementation have been recommended for its treatment. In this study we aimed to evaluate the effects of treatment with ergocalciferol on bone metabolism indexes in hemodialysis patients.In a randomized controlled trial, 40 hemodialysis patients were (...) randomly allocated to the intervention (n = 20) and placebo (n = 20) groups. During the study, 4 patients in the placebo and 1 in the intervention group were excluded. Patients received calcitriol, 0.25 mg/d, with ergocalciferol, 50 000 IU, or placebo weekly for 3 months. Serum levels of 25-hydroxyvitamin D, calcium, parathyroid hormone, and alkaline phosphatase were measured before and after treatment.25-hydroxyvitamin D levels were significantly improved in the intervention group (12.00 ± 4.90 ng/mL

2018 Iranian journal of kidney diseases Controlled trial quality: uncertain

11. Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial. Full Text available with Trip Pro

Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial. Locally produced 1,25-dihydroxyvitamin D3 may have pleiotropic effects outside of bone. Experimental and observational studies suggest that nutritional vitamin D may enhance erythropoiesis in settings of 25-hydroxy vitamin D (25(OH)D) deficiency. We conducted a double-blind, placebo-controlled, randomized clinical trial to assess the effects of supplementation with ergocalciferol (...) on epoetin utilization and other secondary outcomes in patients on hemodialysis with serum 25(OH)D <30 ng/ml. In all, 276 patients were randomized to 6 months of ergocalciferol or placebo. Mean±SD serum 25(OH)D increased from 16.0±5.9 ng/ml at baseline to 39.2±14.9 ng/ml in the ergocalciferol arm and did not change (16.9±6.4 ng/ml and 17.5±7.4 ng/ml, respectively) in the placebo arm. There was no significant change in epoetin dose over 6 months in the ergocalciferol or placebo arms (geometric mean rate

2015 Journal of the American Society of Nephrology : JASN Controlled trial quality: predicted high

12. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial. (Abstract)

Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial. Vitamin D deficiency/insufficiency is common in chronic kidney disease (CKD) patients and it contributes to secondary hyperparathyroidism, which occurs early in CKD. It is not clear whether the Kidney Disease Outcomes Quality Initiative (K/DOQI) recommended doses (...) of ergocalciferol are adequate for correction of vitamin D insufficiency and hyperparathyroidism.To evaluate the parathyroid hormone (PTH)-lowering effect, safety, and tolerability of high-dose ergocalciferol compared with conventional-dose ergocalciferol in CKD subjects.We enrolled CKD stage III-IV patients who had 25-hydroxyvitamin D (25-OH-D) level <30 ng/mL. The patients were randomized into two groups, control group treated with ergocalciferol as recommended by K/DOQI guidelines, and treatment group

2015 Journal of the Medical Association of Thailand = Chotmaihet thangphaet Controlled trial quality: uncertain

13. The stability of ergocalciferol in rodenticidal baits. Full Text available with Trip Pro

The stability of ergocalciferol in rodenticidal baits. Concentrations of the rodenticide ergocalciferol (vitamin D2) in samples of rodent baits laid in foodstores and in the laboratory were monitored over several months. Bait samples were solvent extracted and ergocalciferol concentration determined by high pressure liquid chromatography (HPLC). Ergocalciferol levels were constant for more than 21 days in dry samples and did not fall by more than 30% in 100 days. When water (10% w/w) was added (...) to the baits in the laboratory the ergocalciferol concentration fell by approximately 30% in 30 days. In these wet laboratory samples there was a rapid visible growth of fungus and in normal rodent control use baits should have been replaced when such deterioration became evident.

1983 The Journal of hygiene

14. Efficacy Of Ergocalciferol In Adults According To BMI

Efficacy Of Ergocalciferol In Adults According To BMI Efficacy Of Ergocalciferol In Adults According To BMI - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy Of Ergocalciferol In Adults According (...) attributed to the increasing prevalence of obesity. Several studies have shown that obese patients have lower 25-OH vitamin D (25-OHD) levels compared to nonobese patients and obese patients require more vitamin D compared to nonobese patients. The most commonly prescribed medication to replete vitamin D deficiency is oral ergocalciferol. To date, no prospective trials have been published to evaluate a standard protocol in the treatment of vitamin D insufficiency in adults. Condition or disease

2013 Clinical Trials

15. Ergocalciferol

Ergocalciferol Top results for ergocalciferol - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 (...) or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for ergocalciferol The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other

2018 Trip Latest and Greatest

16. Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels

Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Pilot Study: The Effect (...) of Ergocalciferol on Plasma Mucin-1 Levels The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03747523 Recruitment Status : Not yet recruiting First Posted : November 20, 2018 Last Update Posted : February 15, 2019 See Sponsor: Wake

2018 Clinical Trials

17. Determination of ergocalciferol in human plasma after Diels-Alder derivatization by LC–MS/MS and its application to a bioequivalence study Full Text available with Trip Pro

Determination of ergocalciferol in human plasma after Diels-Alder derivatization by LC–MS/MS and its application to a bioequivalence study An accurate, sensitive and selective method is developed for determination of ergocalciferol (vitamin D2) in human plasma using LC-MS/MS. After liquid-liquid extraction with n-hexane, ergocalciferol was derivatized by reacting with 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD), a strong dienophile based on Diels-Alder reaction. Ergocalciferol and its (...) deuterated internal standard, ergocalciferol-d6, were analyzed on X Select CSH C18 (100 mm×4.6 mm, 2.5 µm) column using acetonitrile and 0.1% (v/v) formic acid in water containing 0.14% methylamine within 6.0 min under gradient elution mode. Tandem mass spectrometry in positive ionization mode was used to quantify ergocalciferol by multiple reaction monitoring (MRM). Entire data processing was done using Watson LIMS™ software which provided excellent data integrity and high throughput with improved

2017 Journal of Pharmaceutical Analysis

18. Plasma transport of ergocalciferol and cholecalciferol and their 25-hydroxylated metabolites in dairy cows. (Abstract)

Plasma transport of ergocalciferol and cholecalciferol and their 25-hydroxylated metabolites in dairy cows. In cattle, there are 2 significant forms of vitamin D: ergocalciferol (ERG) from fungi on roughage and cholecalciferol (CHO) from vitamin supplements or endogenous synthesis in the skin. The hypothesis of the present study is that vitamin D from the 3 sources is transported in different plasma fractions in the body. This is hypothesized to explain the lower efficiency of ERG compared

2017 Domestic animal endocrinology Controlled trial quality: uncertain

19. Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Adults

Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Adults Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Adults - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Adults The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03228862 Recruitment Status : Enrolling by invitation First Posted : July 25, 2017 Last Update Posted : July 26, 2017 Sponsor

2017 Clinical Trials

20. Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease

Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) before adding more. Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03073369 Recruitment Status : Withdrawn (Study didn't materialize for various reasons.) First Posted : March 8, 2017 Last Update Posted : March 15

2017 Clinical Trials